首页> 外国专利> NSAID-CONTAINING TOPICAL FORMULATIONS THAT DEMONSTRATE CHEMOPREVENTIVE ACTIVITY

NSAID-CONTAINING TOPICAL FORMULATIONS THAT DEMONSTRATE CHEMOPREVENTIVE ACTIVITY

机译:证明化学预防活性的含有NSAID的典型配方

摘要

Disclosed herein are chemopreventive methods and topical formulations for theprevention and treatment of ultraviolet light-induced skin cancers, pre-cancerous lesions, and hyperproliferative disorders in mammals, such ashumans, utilizing doses of non-steroidal anti-inflammatory drugs. Low doses ofnon-steroidal anti-inflammatory drugs are present in the topical formulationsand allow continued regular use over an extended period of time to preventsuch disorders. In particular, the present invention is particularly suitablefor non-melanoma skin cancers as these cancers tend to appear in areas of theskin that have had excess sun exposure (head, neck and arms) meaning that thechemopreventive agent would not need to be applied over the entire body of thetypical patient. Moreover, it is possible to identify "high-risk" individualswithin the populations because people who report one episode of NMSC tend tohave a high incidence of a subsequent episode.
机译:本文公开的是化学预防方法和局部制剂。预防和治疗紫外线诱发的皮肤癌,哺乳动物的癌性病变和过度增殖性疾病,例如人类,使用非甾体类抗炎药的剂量。低剂量非甾体类抗炎药存在于局部制剂中并允许长时间连续正常使用以防止这样的疾病。特别地,本发明特别适合非黑色素瘤皮肤癌,因为这些癌症往往会出现在过度暴露在阳光下(头,颈和手臂)的皮肤意味着化学预防剂无需在整个人体上使用典型的病人。此外,有可能识别“高风险”个人在人群中,因为报告了NMSC发作的人群倾向于随后发作的发生率很高。

著录项

  • 公开/公告号CA2474343C

    专利类型

  • 公开/公告日2011-01-04

    原文格式PDF

  • 申请/专利权人 PHARMAQEST PTY LTD;

    申请/专利号CA20032474343

  • 发明设计人 EVANS ALLAN;MCKINNON ROSS;

    申请日2003-01-24

  • 分类号A61K31/192;A61K47/06;A61K47/10;A61K47/32;A61K47/36;A61P17/16;A61Q19;

  • 国家 CA

  • 入库时间 2022-08-21 18:02:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号